8-KOther EventsExhibits & Filings

Medtronic plc 8-K Report, Corporate Update (Mar 31, 2016)

Filed March 31, 2016For Securities:MDT

Summary

Medtronic plc (MDT) announced on March 31, 2016, the commencement of a significant cash tender offer for its outstanding senior notes. This offer, initiated by its wholly-owned subsidiaries Medtronic, Inc. and Covidien International Finance S.A. (CIFSA), aims to purchase up to a combined aggregate of $2.75 billion of various senior notes with different maturity dates and coupon rates. This tender offer represents a strategic move by Medtronic to manage its debt obligations and potentially optimize its capital structure. Investors should note the expiration date of April 27, 2016, and that the full details of the offer are contained in the official offer to purchase documents. The company has provided a press release detailing this event, which is incorporated by reference in this 8-K filing.

Key Highlights

  • 1Medtronic plc commenced a cash tender offer for its senior notes on March 31, 2016.
  • 2The tender offer is being conducted by its subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (CIFSA).
  • 3The maximum aggregate purchase price for the tender offer is $2.75 billion.
  • 4The offer includes various series of senior notes from both Medtronic, Inc. and CIFSA, with differing interest rates and maturity dates.
  • 5The tender offer is set to expire on April 27, 2016, unless extended or terminated.
  • 6A press release detailing the tender offer was issued and filed as an exhibit to the 8-K.

Frequently Asked Questions

The primary purpose of this tender offer is for Medtronic plc to manage its outstanding debt obligations and potentially optimize its capital structure by repurchasing a portion of its senior notes.

The tender offer includes CIFSA's 6.550% Senior Notes due 2037 and 2.950% Senior Notes due 2023, as well as Medtronic, Inc.'s 4.000% Senior Notes due 2043, 2.750% Senior Notes due 2023, 4.450% Senior Notes due 2020, 4.375% Senior Notes due 2035, and 2.500% Senior Notes due 2020.

The tender offer is scheduled to expire at 11:59 p.m., New York City time, on April 27, 2016, unless it is extended or earlier terminated by Medtronic.

More detailed information, including the specific terms and conditions of the tender offer, can be found in the 'offer to purchase' dated March 31, 2016, and the related 'letter of transmittal,' which are referenced in the 8-K filing. The press release (Exhibit 99.1) also provides an announcement of the offer.